Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Evaluation of circulating endothelial biomarkers in familial Mediterranean fever.

Pamuk BO, Sari I, Selcuk S, Gokce G, Kozaci DL.

Rheumatol Int. 2013 Aug;33(8):1967-72. doi: 10.1007/s00296-013-2681-8. Epub 2013 Jan 29.

PMID:
23358733
2.

Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?

Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, Tapan S, Kucukardali Y, Sanisoglu YS, Solmazgul E, Sahan B, Sayan O.

J Rheumatol. 2008 Oct;35(10):2024-9. Epub 2008 Sep 1.

PMID:
18785307
3.

The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever.

Sari I, Yuksel A, Kozaci D, Selcuk S, Gokce G, Yildiz Y, Demirel H, Sop G, Alacacioglu A, Gunay N, Akkoc N.

Inflammation. 2012 Jun;35(3):1191-7. doi: 10.1007/s10753-012-9428-7.

PMID:
22258906
4.

Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever.

Yuksel S, Samli H, Colbay M, Dundar U, Acarturk G, Demir S, Koken T, Aktepe OC, Kavuncu V, Solak M.

Tohoku J Exp Med. 2009 Apr;217(4):321-7.

5.

Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period.

Gerdan V, Sari I, Kozacı D, Önen F, Yüksel F, Soysal O, Solmaz D, Günay N, Akkoc N, Akar S.

Rheumatol Int. 2012 Sep;32(9):2819-22. doi: 10.1007/s00296-011-2094-5. Epub 2011 Aug 30.

PMID:
21877244
6.

Plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in familial Mediterranean fever.

Başar O, Oztürk MA, Köklü S, Ayaz S, Yüksel O, Kiraz S, Ertenli I, Calgüneri M.

Joint Bone Spine. 2007 Jan;74(1):52-5. Epub 2006 Apr 17.

PMID:
17223601
7.

Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.

Kiraz S, Ertenli I, Arici M, Calgüneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S.

Clin Exp Rheumatol. 1998 Nov-Dec;16(6):721-4.

PMID:
9844766
8.

Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever.

Erken E, Ozer HT, Gunesacar R.

Rheumatol Int. 2006 Jul;26(9):862-4. Epub 2006 Jan 6.

PMID:
16397779
9.

Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever.

Yildirim K, Uzkeser H, Keles M, Karatay S, Kiziltunc A, Kaya MD, Yildirim A.

Biochem Med (Zagreb). 2012;22(1):109-13.

10.

Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever.

Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A.

Rheumatol Int. 2007 Jul;27(9):807-11. Epub 2007 Jan 17.

PMID:
17225924
11.

Cytokine profile of Armenian patients with Familial Mediterranean fever.

Manukyan GP, Ghazaryan KA, Ktsoyan ZhA, Tatyan MV, Khachatryan ZA, Hakobyan GS, Mkrtchyan VA, Kelly D, Coutts A, Aminov RI.

Clin Biochem. 2008 Jul;41(10-11):920-2. doi: 10.1016/j.clinbiochem.2008.03.017. Epub 2008 Apr 11.

PMID:
18440310
12.

Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.

Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F.

Clin Rheumatol. 2007 Sep;26(9):1467-73. Epub 2007 Jan 23.

PMID:
17242867
13.

Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever.

Kisacik B, Akdogan A, Yilmaz G, Karadag O, Yilmaz FM, Koklu S, Yuksel O, Ertenli AI, Kiraz S.

Eur J Intern Med. 2009 Jan;20(1):44-7. doi: 10.1016/j.ejim.2008.04.020. Epub 2008 Jun 20.

PMID:
19237091
14.

Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever.

Haznedaroglu S, Oztürk MA, Sancak B, Goker B, Onat AM, Bukan N, Ertenli I, Kiraz S, Calguneri M.

Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S77-80.

PMID:
16273770
15.

S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever.

Taylan A, Gurler O, Toprak B, Sisman AR, Yalcin H, Colak A, Sari I.

J Korean Med Sci. 2015 Sep;30(9):1241-5. doi: 10.3346/jkms.2015.30.9.1241. Epub 2015 Aug 13.

16.

Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever.

Ozel AM, Demirturk L, Aydogdu A, Gultepe M, Yazgan Y, Imirzalioglu N, Gurbuz AK, Narin Y.

Int J Clin Pract. 2008 May;62(5):754-61. Epub 2007 Mar 1.

PMID:
17343670
17.

Continuity of cytokine activation in patients with familial Mediterranean fever.

Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, Gulsen M, Karaeren N, Dagalp K.

Clin Rheumatol. 2004 Aug;23(4):333-7. Epub 2004 May 1.

PMID:
15293095
18.

Is Familial Mediterranean Fever a thrombotic disease or not?

Demirel A, Celkan T, Kasapcopur O, Bilgen H, Ozkan A, Apak H, Arisoy N, Yildiz I.

Eur J Pediatr. 2008 Mar;167(3):279-85. Epub 2007 Apr 14.

PMID:
17436016
19.

Circulating thrombomodulin levels in familial Mediterranean fever.

Ozbalkan Z, Ozturk MA, Onat AM, Ureten K, Haznedaroglu IC, Kiraz S, Ertenli AI, Kirazli S, Calguneri M.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S95-8. Erratum in: Clin Exp Rheumatol. 2007 May-Jun;25(3):507-8.

PMID:
17067436
20.

The value of procalcitonin measurements in children with familial Mediterranean fever.

Yüksel S, Ekim M, Ozçakar ZB, Yalçınkaya F, Acar B, Oztuna D, Akar N.

Rheumatol Int. 2012 Nov;32(11):3443-7. doi: 10.1007/s00296-011-2206-2. Epub 2011 Nov 6.

PMID:
22057145
Items per page

Supplemental Content

Write to the Help Desk